Olson Kenneth R
Indiana University School of Medicine-South Bend, 1234 Notre Dame Avenue, South Bend, IN 46617, USA.
Biochim Biophys Acta. 2009 Jul;1787(7):856-63. doi: 10.1016/j.bbabio.2009.03.019. Epub 2009 Apr 8.
Hydrogen sulfide (H(2)S) is gaining acceptance as a signaling molecule and has been shown to elicit a variety of biological effects at concentrations between 10 and 1000 micromol/l. Dissolved H(2)S is a weak acid in equilibrium with HS(-) and S(2-) and under physiological conditions these species, collectively referred to as sulfide, exist in the approximate ratio of 20% H(2)S, 80% HS(-) and 0% S(2-). Numerous analyses over the past 8 years have reported plasma or blood sulfide concentrations also in this range, typically between 30 and 300 micromol/l, thus supporting the biological studies. However, there is some question whether or not these concentrations are physiological. First, many of these values have been obtained from indirect methods using relatively harsh chemical conditions. Second, most studies conducted prior to 2000 failed to find blood sulfide in micromolar concentrations while others showed that radiolabeled (35)S-sulfide is rapidly removed from blood and that mammals have a relatively high capacity to metabolize exogenously administered sulfide. Very recent studies using H(2)S gas-sensing electrodes to directly measure sulfide in plasma or blood, or HPLC analysis of head-space gas, have also indicated that sulfide does not circulate at micromolar levels and is rapidly consumed by blood or tissues. Third, micromolar concentrations of sulfide in blood or exhaled air should be, but are not, malodorous. Fourth, estimates of dietary sulfur necessary to sustain micromolar levels of plasma sulfide greatly exceed the daily intake. Collectively, these studies imply that many of the biological effects of sulfide are only achieved at supra-physiological concentrations and they question whether circulating sulfide is a physiologically relevant signaling molecule. This review examines the blood/plasma sulfide measurements that have been reported over the past 30 years from the perspective of the analytical methods used and the potential sources of error.
硫化氢(H₂S)作为一种信号分子正逐渐被认可,并且已表明在10至1000微摩尔/升的浓度范围内会引发多种生物学效应。溶解的H₂S是一种弱酸,与HS⁻和S²⁻处于平衡状态,在生理条件下,这些物质统称为硫化物,它们以大约20%的H₂S、80%的HS⁻和0%的S²⁻的比例存在。过去8年的大量分析报告称血浆或血液中的硫化物浓度也在此范围内,通常在30至300微摩尔/升之间,从而支持了生物学研究。然而,这些浓度是否为生理浓度存在一些疑问。首先,这些值中的许多是通过使用相对苛刻化学条件的间接方法获得的。其次,2000年之前进行的大多数研究未能在微摩尔浓度下发现血液中的硫化物,而其他研究表明放射性标记的³⁵S-硫化物会迅速从血液中清除,并且哺乳动物对外源性给予的硫化物具有相对较高的代谢能力。最近使用H₂S气敏电极直接测量血浆或血液中的硫化物,或对顶空气体进行高效液相色谱分析的研究也表明,硫化物并非以微摩尔水平循环,而是会被血液或组织迅速消耗。第三,血液或呼出气体中微摩尔浓度的硫化物应该有气味,但实际上却没有。第四,维持血浆硫化物微摩尔水平所需的膳食硫估计值大大超过每日摄入量。总体而言,这些研究表明硫化物的许多生物学效应仅在超生理浓度下才能实现,并且它们质疑循环中的硫化物是否是一种生理相关的信号分子。本综述从所使用的分析方法和潜在误差来源的角度,审视了过去30年中报道的血液/血浆硫化物测量结果。